Weber WA - Search Results

1

Early Experience of Rechallenge ¹⁷⁷Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer.

Gafita A, Rauscher I, Retz M, Knorr K, Heck M, Wester HJ, D'Alessandria C, Weber WA, Eiber M, Tauber R. Gafita A, et al. Among authors: weber wa. J Nucl Med. 2019 May;60(5):644-648. doi: 10.2967/jnumed.118.215715. Epub 2018 Nov 15. J Nucl Med. 2019. PMID: 30442756 Free article.

2

Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.

Weber W, Bartenstein P, Gross MW, Kinzel D, Daschner H, Feldmann HJ, Reidel G, Ziegler SI, Lumenta C, Molls M, Schwaiger M. Weber W, et al. J Nucl Med. 1997 May;38(5):802-8. J Nucl Med. 1997. PMID: 9170450 Free article.

3

Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.

Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, Stöcklin G. Wester HJ, et al. J Nucl Med. 1999 Jan;40(1):205-12. J Nucl Med. 1999. PMID: 9935078 Free article.

4

Reproducibility of metabolic measurements in malignant tumors using FDG PET.

Weber WA, Ziegler SI, Thödtmann R, Hanauske AR, Schwaiger M. Weber WA, et al. J Nucl Med. 1999 Nov;40(11):1771-7. J Nucl Med. 1999. PMID: 10565769 Free article. Clinical Trial.

5

O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.

Weber WA, Wester HJ, Grosu AL, Herz M, Dzewas B, Feldmann HJ, Molls M, Stöcklin G, Schwaiger M. Weber WA, et al. Eur J Nucl Med. 2000 May;27(5):542-9. doi: 10.1007/s002590050541. Eur J Nucl Med. 2000. PMID: 10853810 Clinical Trial.

6

Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.

Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M. Haubner R, et al. J Nucl Med. 2001 Feb;42(2):326-36. J Nucl Med. 2001. PMID: 11216533 Free article.

7

Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.

Haubner R, Wester HJ, Weber WA, Mang C, Ziegler SI, Goodman SL, Senekowitsch-Schmidtke R, Kessler H, Schwaiger M. Haubner R, et al. Among authors: weber wa. Cancer Res. 2001 Mar 1;61(5):1781-5. Cancer Res. 2001. PMID: 11280722

8

Tumor angiogenesis targeting using imaging agents.

Weber WA, Haubner R, Vabuliene E, Kuhnast B, Wester HJ, Schwaiger M. Weber WA, et al. Q J Nucl Med. 2001 Jun;45(2):179-82. Q J Nucl Med. 2001. PMID: 11476168 Review.

9

Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas.

Weber WA, Dick S, Reidl G, Dzewas B, Busch R, Feldmann HJ, Molls M, Lumenta CB, Schwaiger M, Grosu AL. Weber WA, et al. J Nucl Med. 2001 Aug;42(8):1144-50. J Nucl Med. 2001. PMID: 11483672 Free article.

10

O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.

Rau FC, Weber WA, Wester HJ, Herz M, Becker I, Krüger A, Schwaiger M, Senekowitsch-Schmidtke R. Rau FC, et al. Among authors: weber wa. Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1039-46. doi: 10.1007/s00259-002-0821-6. Epub 2002 May 28. Eur J Nucl Med Mol Imaging. 2002. PMID: 12173018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters